B. Kaffenberger

发表

Ros‐NET: A deep convolutional neural network for automatic identification of rosacea lesions

Hamidullah Binol, Metin N Gurcan, Muhammad Khalid Khan Niazi, 2019, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

The Therapy of Cutaneous T Cell Lymphoma

P. Porcu, B. Kaffenberger, M. Bechtel, 2016 .

Skin diseases associated with Agent Orange and other organochlorine exposures.

B. Kaffenberger, D. Elston, Andrew T. Patterson, 2015, Journal of the American Academy of Dermatology.

Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi‐centre study

B. Kaffenberger, M. Shinohara, Phoebe Hammer, 2019, International wound journal.

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines

M. Lacouture, M. Anadkat, G. Abou-Alfa, 2020, The oncologist.

A retrospective study of myocardial abnormalities detected on cardiac magnetic resonance imaging among patients with psoriasis compared to inflammatory skin disease controls

S. Raman, B. Kaffenberger, J. Kaffenberger, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Sosman, M. Dwyer, B. Kaffenberger, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Immunotargeting in the management of psoriasis

B. Kaffenberger, H. Wong, T. Kaffenberger, 2013, ImmunoTargets and therapy.

ImmunoTargets and Therapy Immunotargeting in the management of psoriasis

B. Kaffenberger, H. Wong, T. Kaffenberger, 2013 .

Dermal and Subcutaneous Chronic Graft-Versus-Host Disease

B. Kaffenberger, S. Jaglowski, 2017 .

Cutaneous Manifestations of Infections in Solid Organ Transplant Recipients

B. Kaffenberger, Cory Pettit, K. Mazurek, 2018, Current Infectious Disease Reports.

Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues.

M. Grever, L. Andritsos, B. Kaffenberger, 2019, Journal of the American Academy of Dermatology.

Response to: ‘Validation of generalized drug‐related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes’: reply from the authors

B. Kaffenberger, S. Krishna, J. Trinidad, 2022 .

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

A. Dobry, B. Kaffenberger, S. Himed, 2022, Frontiers in Medicine.

The Effect of Implementing Teledermatology in Patients Presenting with Cellulitis Versus Pseudocellulitis in an Academic Emergency Department Setting: A Pilot Study.

B. Kaffenberger, E. Adkins, A. Wells, 2020, The Journal of clinical and aesthetic dermatology.

Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.

James X. Sun, L. Strowd, B. Kaffenberger, 2020, Journal of the American Academy of Dermatology.

First‐ and third‐generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions

C. Vasavda, B. Kaffenberger, S. Kwatra, 2020, The British journal of dermatology.

Viral exanthems: An update on laboratory testing of the adult patient

B. Kaffenberger, A. Korman, A. Alikhan, 2017, Journal of the American Academy of Dermatology.

Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis

B. Kaffenberger, C. Chung, Michelle Boettler, 2021, American Journal of Clinical Dermatology.

Cannabinoids for the Treatment of Chronic Pruritus: A Review.

B. Kaffenberger, S. Kwatra, M. Bechtel, 2020, Journal of the American Academy of Dermatology.

Current and potential immune therapies and vaccines in the management of psoriasis

B. Kaffenberger, W. Jarjour, M. Williams, 2014, Human vaccines & immunotherapeutics.

Generic, twice‐daily minocycline versus branded, extended‐release minocycline for acne: A retrospective comparison of treatment escalation

Jennifer A. Sopkovich, B. Kaffenberger, Preeta Gupta, 2017, Journal of the American Academy of Dermatology.

Perianal Tumor With Overlap Features of Fibroadenoma and Phyllodes Tumor Arising From Anogenital Mammary-like Glands.

B. Kaffenberger, A. Gru, J. R. Duncan, 2016, The American Journal of dermatopathology.

Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell–Deficient Milieu

B. Kaffenberger, B. Bolon, Rahul Sharma, 2013, Arthritis and rheumatism.

Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine.

B. Ramaswamy, B. Kaffenberger, Michael Berger, 2019, The Journal of clinical and aesthetic dermatology.

A chimeric human–mouse model of Sjögren's syndrome

M. Bruss, B. Kaffenberger, B. Bolon, 2014, Clinical immunology.

A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis.

B. Kaffenberger, M. Zirwas, J. Mathis, 2014, Journal of the American Academy of Dermatology.

Cutaneous Adverse Reactions of Anticancer Agents.

B. Kaffenberger, S. Kwatra, S. Kaul, 2019, Dermatologic clinics.

In-Vitro Diagnostics for the Medical Dermatologist: Part 2: Hypercoagulability Tests.

B. Kaffenberger, J. Kaffenberger, S. Dean, 2021, Journal of the American Academy of Dermatology.

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Matthew J. Frigault, J. Sosman, M. Ernstoff, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

The cutaneous expression of vitamin K-dependent and other osteogenic proteins in calciphylaxis stratified by clinical features and warfarin use: A case control study.

Steven W. Ing, B. Kaffenberger, A. Gru, 2016, Journal of the American Academy of Dermatology.

Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin.

P. Porcu, B. Kaffenberger, H. Wong, 2013, The Journal of clinical and aesthetic dermatology.

Psoriasiform graft‐versus‐host disease distributed along Blaschko's lines

B. Kaffenberger, A. Gru, Philip B. Milam, 2017, Journal of cutaneous pathology.

Generalized eruptive histiocytomas and rosai-dorfman disease presenting concurrently in a patient with myelodysplastic syndrome.

B. Kaffenberger, S. Peters, M. Bechtel, 2012, The Journal of clinical and aesthetic dermatology.

Two cases of atypical periorificial dermatitis caused by Candida parapsilosis in patients volunteering in dog shelters.

B. Kaffenberger, S. Diaz, C. Pettit, 2019, Dermatology online journal.

Pseudocellulitis Need Not be Benign: Three Cases of Superficial Migratory Thrombophlebitis with "Negative" Venous Duplex Ultrasonography.

B. Kaffenberger, S. Dean, Robert N Malinak, 2017, The Journal of clinical and aesthetic dermatology.

Fibrous Proliferations in Posttransplant Kaposi Sarcoma.

B. Kaffenberger, A. Gru, Philip B. Milam, 2021, The Journal of clinical and aesthetic dermatology.

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.

J. Byrd, J. Ritz, D. Munn, 2014, The Journal of clinical investigation.

Chronic graft-versus-host disease (cGVHD) is a life-threatening impediment to allogeneic hematopoietic stem cell transplantation, and current therapies do not completely prevent and/or treat cGVHD. CD4

J. Byrd, J. Ritz, D. Munn, 2014 .

Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma

B. Kaffenberger, A. Korman, K. Tyler, 2017, International journal of dermatology.

Novel Chromosome 5 Inversion Associated With PDGFRB Rearrangement in Hypereosinophilic Syndrome.

N. Heerema, B. Kaffenberger, R. Klisovic, 2016, JAMA dermatology.

JAAD grand rounds. Persistent and progressive purpura in a patient with an elevated rheumatoid factor and polyclonal gammopathy (hypergammaglobulinemic purpura of Waldenström).

B. Kaffenberger, M. Bechtel, M. Zirwas, 2015, Journal of the American Academy of Dermatology.

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

B. Kaffenberger, J. Gudjonsson, M. Rosenbach, 2020, Drugs in R&D.

Asymptomatic Green-Gray Nodules on the Chest.

B. Kaffenberger, C. Chung, M. Amigo, 2020, JAMA dermatology.

SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist

B. Kaffenberger, S. Himed, A. Korman, 2022, Current dermatology reports.

The Association Between Oral Health and Skin Disease.

B. Kaffenberger, J. Kaffenberger, Purnima S. Kumar, 2020, The Journal of clinical and aesthetic dermatology.

OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)

K. Kalunian, B. Kaffenberger, S. Navarra, 2020, Annals of the Rheumatic Diseases.

Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study

B. Kaffenberger, S. Himed, N. Spaccarelli, 2022, American Journal of Clinical Dermatology.

Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation.

L. Andritsos, B. Kaffenberger, W. Jarjour, 2013, Journal of the American Academy of Dermatology.

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

M. Lacouture, F. Grosso, M. Anadkat, 2023, Frontiers in Oncology.

NCCN: Continuing Education

Matthew J. Frigault, J. Sosman, M. Ernstoff, 2019 .

Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology

B. Kaffenberger, C. Chung, Andrew T. Patterson, 2023, International journal of dermatology.

Calciphylaxis associated with the fibroblast growth factor receptor inhibitor erdafitinib

B. Kaffenberger, C. Chung, P. Macklis, 2020, JAAD case reports.

Association of Dermatology Consultations With Patient Care Outcomes in Hospitalized Patients With Inflammatory Skin Diseases

B. Kaffenberger, N. Milani-Nejad, Myron Zhang, 2017, JAMA dermatology.

Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

A. Plotner, B. Kaffenberger, S. Devine, 2014, Journal of the American Academy of Dermatology.

An analysis of inpatient consultations evaluating for incidental skin cancers in an academic hospital.

B. Kaffenberger, J. Hosmer-Quint, N. Spaccarelli, 2022, International journal of dermatology.

Vandetanib-induced Phototoxic Drug Eruption Treated with Polypodium Leucotomos Extract: A Case Report and Review of the Literature.

B. Kaffenberger, M. Shah, B. Konda, 2019, The Journal of clinical and aesthetic dermatology.

Clinical and immunologic differences in cellulitis vs. pseudocellulitis

B. Kaffenberger, M. Goldenberg, Trent D. Walker, 2021, Expert review of clinical immunology.

Occluded Cigarette Smoke Exposure Causing Localized Chloracne-Like Comedones

B. Kaffenberger, D. Elston, Andrew T. Patterson, 2015, Dermatology.

Approaching Target and Targetoid Eruptions in Inpatient Dermatology

B. Kaffenberger, Alecia M. Blaszczak, A. Cartron, 2020, Current Dermatology Reports.

The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey

B. Kaffenberger, A. Hinton, S. Krishna, 2018, Journal of the American Academy of Dermatology.

In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests.

B. Kaffenberger, J. Kaffenberger, A. Korman, 2021, Journal of the American Academy of Dermatology.

Bedside Diagnostic Techniques in Dermatology

B. Kaffenberger, N. Spaccarelli, A. Korman, 2021, Current Dermatology Reports.

PATHOGENESIS OF THE RESPONSE TO AIRBORNE PROTEINS

B. Kaffenberger, M. Zirwas, Todd L. Hostetler, 2010 .

The role of airborne proteins in atopic dermatitis.

B. Kaffenberger, M. Zirwas, Todd L. Hostetler, 2010, The Journal of clinical and aesthetic dermatology.

Successful treatment of inflammatory linear verrucous epidermal nevus (ILVEN) with 308‐nm excimer laser: Patient patient required

B. Kaffenberger, C. Chung, Rebecca F Wang, 2019, Photodermatology, photoimmunology & photomedicine.

Unresponsive flesh‐colored papules on the face

B. Kaffenberger, C. Chung, M. Amigo, 2022, International journal of dermatology.

Infectious panniculitis: an inpatient cohort

B. Kaffenberger, M. McGrath, C. Chung, 2021, International journal of dermatology.

Diagnosis uPGrade-Advances in Pyoderma Gangrenosum.

B. Kaffenberger, J. Trinidad, 2018, JAMA dermatology.

The impact of comorbidity identification on outcomes in pyoderma gangrenosum: a retrospective cohort study of previously hospitalized patients.

B. Kaffenberger, N. Spaccarelli, J. Trinidad, 2021, Journal of the American Academy of Dermatology.

Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes

B. Kaffenberger, J. Westerdahl, A. Ortega‐Loayza, 2021, The Journal of dermatological treatment.

Budesonide capsules for peristomal pyoderma gangrenosum.

B. Kaffenberger, Michelle Boettler, 2021, Journal of the American Academy of Dermatology.

Clinical and therapeutic overlap of pyoderma gangrenosum, cutaneous small vessel vasculitis, and immunoglobulin A

B. Kaffenberger, J. Kaffenberger, C. Chung, 2020, International journal of dermatology.

B. Kaffenberger, A. Ortega‐Loayza, K. Nusbaum, 2021, Journal of the American Academy of Dermatology.

B. Kaffenberger, K. Nusbaum, 2021 .

Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study

B. Kaffenberger, S. Kwatra, M. Belzberg, 2020, Medicines.

Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic

B. Kaffenberger, D. Kroshinsky, J. Trinidad, 2020, Journal of the American Academy of Dermatology.

A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia

M. Lacouture, M. Anadkat, B. Kaffenberger, 2019, Investigational New Drugs.

Concordance of diagnostic modalities in atypical skin and soft tissue infections in hospitalized patients.

B. Kaffenberger, C. Chung, J. Trinidad, 2022, Archives of dermatological research.

Office‐based dermatologic diagnostic procedure utilization in the United States Medicare population from 2000‐2016

B. Kaffenberger, A. Guzman, 2019, International journal of dermatology.

Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus

R. Stern, C. Bodemer, L. French, 2021, The British journal of dermatology.

Pasteurella multocida ecthyma complicated by necrotizing fasciitis.

B. Kaffenberger, N. Milani-Nejad, K. Tyler, 2017, Dermatology online journal.

The frequency of low‐risk morbilliform drug eruptions observed in patients treated with different classes of antibiotics

B. Kaffenberger, Andrew J Krispinsky, Lydia Shedlofsky, 2020, International journal of dermatology.

Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.

Murugesan V. S. Rajaram, B. Rovin, D. Birmingham, 2013, Molecular immunology.

Angiosarcoma-like Kaposi Sarcoma

B. Kaffenberger, P. Wakely, J. Plaza, 2022, The American journal of surgical pathology.

A hybrid tumor with schwannoma‐perineurioma‐neurofibroma morphology

B. Kaffenberger, Colin T. McLaughlin, Alejandro A. Gru, 2015, Journal of cutaneous pathology.

Purpura Annularis Telangiectodes of Majocchi Associated With the Initiation and Rechallenge of Apremilast for Psoriasis Vulgaris.

B. Kaffenberger, M. Bechtel, A. Gru, 2017, JAMA dermatology.

Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder.

P. Porcu, B. Kaffenberger, A. Gru, 2015, The American Journal of dermatopathology.

Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care Center

B. Kaffenberger, S. Ständer, J. Szepietowski, 2019, Medicines.

The effect of climate change on skin disease in North America

B. Kaffenberger, M. Rosenbach, S. Norton, 2017, Journal of the American Academy of Dermatology.

University of Groningen Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis

R. Stern, C. Bodemer, A. Paller, 2021 .

The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer.

B. Kaffenberger, J. R. Duncan, David R. Carr, 2016, Journal of the American Academy of Dermatology.

Multifocal epithelial hyperplasia (Heck disease) in a patient with chronic lymphocytic leukemia

L. Andritsos, B. Kaffenberger, A. Gru, 2014, Journal of cutaneous pathology.

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States.

Shayna L Gordon, D. Margolis, L. Hughey, 2018, The Journal of investigative dermatology.

Discordant molecular tests for acute Graft-Versus-Host Disease after liver transplant: FISHing for the proper diagnosis.

Weiqiang Zhao, B. Kaffenberger, S. Shearer, 2019, Dermatology online journal.

Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review

B. Kaffenberger, R. Mital, Sabrina Amin, 2022, Dermatology and Therapy.

Unusual presentation of erythema elevatum diutinum with underlying hepatitis B infection.

B. Kaffenberger, S. Peters, K. Tyler, 2018, Cutis.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10

D. Margolis, R. Hubbard, L. Hughey, 2019, JAMA dermatology.

Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib Therapy.

B. Kaffenberger, M. Shah, E. Bertino, 2016, JAMA dermatology.

Telemedicine and dermatology hospital consultations during the COVID‐19 pandemic: a multi‐centre observational study on resource utilization and conversion to in‐person consultations during the COVID‐19 pandemic

B. Kaffenberger, A. Markova, S. Daveluy, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Local recurrence rate of fine‐needle aspiration biopsy in primary high‐grade sarcomas

J. Mayerson, B. Kaffenberger, P. Wakely, 2010, Journal of surgical oncology.

Predictors of 30-day Readmission in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective, Cross-sectional Database Study.

B. Kaffenberger, S. Kwatra, A. Guzman, 2020, Journal of the American Academy of Dermatology.

SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist

B. Kaffenberger, S. Himed, A. Korman, 2022, Current dermatology reports.

Novel cutaneous eruptions in the setting of programmed cell death protein 1 inhibitor therapy

B. Kaffenberger, A. Cartron, N. Spaccarelli, 2022, JAAD case reports.

Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients

B. Kaffenberger, J. Kaffenberger, S. Kwatra, 2021, Archives of Dermatological Research.

Squamous Cell Carcinoma Arising From Keratoacanthoma : An Evaluation by RT-PCR

B. Kaffenberger, A. L. Salavaggione, A. Gru, 2016 .

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus

C. Sotozono, B. Kaffenberger, S. Rauz, 2023, Orphanet Journal of Rare Diseases.

Academic dermatologists' views on the value of residency letters of recommendation.

B. Kaffenberger, J. Kaffenberger, M. Zirwas, 2014, Journal of the American Academy of Dermatology.

Cutaneous macroglobulinosis as the initial presentation of Waldenström macroglobulinemia in a patient with a history of diffuse large B‐cell lymphoma

B. Kaffenberger, A. Gru, Aria Shakeri, 2018, Journal of cutaneous pathology.

Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.

Murugesan V. S. Rajaram, C. Burd, B. Kaffenberger, 2014, Clinical immunology.

Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty

J. Silverberg, B. Kaffenberger, Myron Zhang, 2017, Journal of the American Academy of Dermatology.

Optimizing Management of Otophyma: A Case Series Highlighting the Role of Surgical and Retinoid Therapy

B. Kaffenberger, E. Dodson, M. Paradiso, 2020, Ear, nose, & throat journal.

A retrospective cohort study of infection risk in hospitalized patients evaluated for Sweet syndrome

B. Kaffenberger, C. Chung, J. Trinidad, 2022, Archives of Dermatological Research.

A Retrospective Analysis Comparing the New Standardized Letter of Recommendation in Dermatology with the Classic Narrative Letter of Recommendation.

A. Plotner, B. Kaffenberger, J. Kaffenberger, 2016, The Journal of clinical and aesthetic dermatology.

Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series

Jennifer A. Sopkovich, B. Kaffenberger, K. Nusbaum, 2021, International journal of dermatology.

Improved Patient Access and Outcomes with the Integration of an eConsult Program (Teledermatology) within a Large Academic Medical Center.

B. Kaffenberger, E. Levine, M. Rizer, 2019, Journal of the American Academy of Dermatology.

Characterizing risk factors for hospitalization for psoriasis patients

B. Kaffenberger, J. Kaffenberger, J. Gudjonsson, 2021, Archives of dermatological research.

Single Model Deep Learning on Imbalanced Small Datasets for Skin Lesion Classification

Ronald X. Xu, Pengfei Shao, B. Kaffenberger, 2021, IEEE Transactions on Medical Imaging.

Magnetic resonance elastography and transient elastography as non‐invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?

B. Kaffenberger, J. Kaffenberger, M. Bechtel, 2015, International journal of dermatology.

Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases

B. Kaffenberger, Y. Elshot, C. Carrera, 2023, Melanoma research.

Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation - a retrospective chart review.

L. Hughey, B. Kaffenberger, A. Jani, 2020, Journal of the American Academy of Dermatology.

The use of high resolution optical coherence tomography to evaluate robotic radical prostatectomy specimens.

Benjamin Kaffenberger, Vipul R Patel, V. Patel, 2009, International braz j urol : official journal of the Brazilian Society of Urology.

Bullae and psoriasiform hyperkeratosis after treatment with golimumab.

B. Kaffenberger, L. Madigan, H. Wong, 2013, Journal of the American Academy of Dermatology.

Kaposi sarcoma: An unconventional cause of lower extremity lymphedema

B. Kaffenberger, S. Dean, M. Lustberg, 2017, Vascular medicine.

Recurrent Life-Threatening Deep Tissue Hematomas After Switching to Generic Enoxaparin: A Report and Perspective on the Approval Process for Biological Compounds

T. Bekaii-Saab, B. Kaffenberger, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

IgA Expression in Adult Cutaneous Leukocytoclastic Vasculitis and its Effect on Hospital Outcomes.

B. Kaffenberger, S. Kwatra, C. Chung, 2020, Journal of the American Academy of Dermatology.

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.

K. Kalunian, B. Kaffenberger, S. Navarra, 2022, The New England journal of medicine.

Follicular Induction Changes Overlying a Melanocytic Nevus.

B. Kaffenberger, A. L. Salavaggione, A. Gru, 2016, The American Journal of dermatopathology.

The utility of augmented teledermatology to improve dermatologist diagnosis of cellulitis: a cross-sectional study

B. Kaffenberger, M. Rosenbach, A. Mostaghimi, 2022, Archives of Dermatological Research.

Advances in acute exanthemas

B. Kaffenberger, N. Milani-Nejad, S. Shearer, 2019, The British journal of dermatology.

Recognizing cutaneous signs of addiction: the “shooter's patch” and surrounding buckshot tattoos

B. Kaffenberger, C. Chung, R. Mital, 2022, International journal of dermatology.

A multidimensional scaling and sample clustering to obtain a representative subset of training data for transfer learning-based rosacea lesion identification

Metin N. Gurcan, M. Khalid Khan Niazi, Hamidullah Binol, 2020, Medical Imaging.

A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology.

B. Kaffenberger, M. Rosenbach, A. Mostaghimi, 2020, Journal of the American Academy of Dermatology.

Impact of Dermatology and Teledermatology Consultations for Patients Admitted with Cellulitis: A Pilot Study.

B. Kaffenberger, Myron Zhang, Preeta Gupta, 2020, Journal of the American Academy of Dermatology.

Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease.

J. Kvedar, L. Strowd, B. Kaffenberger, 2020, Journal of the American Academy of Dermatology.

Acne image analysis: lesion localization and classification

Metin Nafi Gürcan, Fazly Salleh Abas, Benjamin Kaffenberger, 2016, SPIE Medical Imaging.

Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil

B. Kaffenberger, S. Jaglowski, A. Mims, 2023, JAAD case reports.

Endothelial chimerism in chronic sclerotic‐type chronic graft‐versus‐host disease (GVHD) and GVHD‐associated angiomatosis

B. Kaffenberger, S. Devine, S. Jaglowski, 2016, The British journal of dermatology.

Trends and Scope of Dermatology Procedures Billed by Advanced Practice Professionals From 2012 Through 2015

B. Kaffenberger, J. Zippin, Myron Zhang, 2018, JAMA dermatology.

A virtual faculty exchange program enhances dermatology resident education in the COVID-19 era: a survey study.

B. Kaffenberger, A. Atwater, L. Madigan, 2021, Dermatology online journal.

A palpable erythematous cord over the trunk in a patient with systemic lupus erythematosus. Interstitial granulomatous dermatitis (IGD).

B. Kaffenberger, M. Zirwas, H. Wong, 2013, JAMA dermatology.

Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States

B. Kaffenberger, J. Trinidad, N. Milani-Nejad, 2020 .

A Case of Vancomycin-induced Acute Generalized Exanthematous Pustulosis Confirmed by Patch Testing.

B. Kaffenberger, J. Trinidad, C. Pettit, 2020, The Journal of clinical and aesthetic dermatology.

Acquired Pili Torti.

B. Kaffenberger, J. Hastings, J. Evans, 2019, JAMA dermatology.

Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition

B. Kaffenberger, A. Gru, Sabrina M. Smith, 2016, JAAD case reports.

Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa

M. Anadkat, B. Kaffenberger, J. Kaffenberger, 2022, medRxiv.

Anti–melanoma differentiation–associated gene 5 dermatomyositis complicated by myopericarditis

B. Kaffenberger, J. Trinidad, N. Milani-Nejad, 2019, JAAD case reports.

Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.

C. Querfeld, B. Kaffenberger, M. Shinohara, 2023, JAMA dermatology.

Study Protocol: Role of Intermittent Fasting on Disease Severity and Quality of Life in Psoriasis and Psoriatic Arthritis: A Single-Blind Parallel Group Randomized Control Trial

Jennifer A. Sopkovich, B. Kaffenberger, J. Kaffenberger, 2023, Academic Dermatology.

The cost of topical immunomodulator therapy in Medicare patients varies by prescriber specialty

J. Silverberg, B. Kaffenberger, Myron Zhang, 2017, Journal of American Academy of Dermatology.

Erythema Ab Igne in a Patient with Chronic Pancreatitis

B. Kaffenberger, P. Hart, Mitchell L. Ramsey, 2023, ACG Case Reports Journal.

A cross‐sectional hospital study of erythroderma

B. Kaffenberger, N. Spaccarelli, J. Trinidad, 2020, International journal of dermatology.

Purpuric patches and telangiectasias on the chest

B. Kaffenberger, A. Korman, C. Chung, 2020, JAAD case reports.

Supplemental materials for publication: Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.

James X. Sun, L. Strowd, B. Kaffenberger, 2020 .

Factitial dermatitis in the hospital setting

B. Kaffenberger, K. Nusbaum, J. Trinidad, 2022, Archives of Dermatological Research.

Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab

B. Kaffenberger, S. Vasu, Sara B Huff, 2019, International journal of dermatology.

Detection of novel therapies using a multi‐national, multi‐institutional registry of cutaneous immune‐related adverse events and management

B. Kaffenberger, A. Markova, A. Freites-Martinez, 2023, International Journal of Dermatology.

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid

T. Olencki, B. Kaffenberger, S. Scrape, 2018, International journal of dermatology.

Quality of Life with Neutrophilic Dermatoses.

B. Kaffenberger, R. Mital, Margo Waters, 2023, Dermatologic clinics.

The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins.

B. Kaffenberger, J. Kaffenberger, N. Spaccarelli, 2021, Journal of the American Academy of Dermatology.

The Epidemiology, Impact, and Diagnosis of Micronutrient Nutritional Dermatoses Part 1: Zinc, Selenium, Copper, Vitamin A, and Vitamin C.

B. Kaffenberger, P. Hart, J. Kaffenberger, 2021, Journal of the American Academy of Dermatology.

Reply to "Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation - a retrospective chart review."

B. Kaffenberger, L. Seminario-Vidal, J. Keller, 2019, Journal of the American Academy of Dermatology.

Characterizing risk factors for hospitalization for psoriasis patients

B. Kaffenberger, J. Kaffenberger, J. Gudjonsson, 2023, Archives of Dermatological Research.

Defining Drugs that are High-Risk Associations for Drug Reactions Within the Hospital Setting.

B. Kaffenberger, M. Rosenbach, J. Trinidad, 2021, The Journal of clinical and aesthetic dermatology.

Dermatology-Specific and All-Cause 30-Day and Calendar-Year Readmissions and Costs for Dermatologic Diseases from 2010-2014.

S. Dusza, B. Kaffenberger, M. Rosenbach, 2019, Journal of the American Academy of Dermatology.

The Validity of Pyoderma Gangrenosum ICD9-CM Coding in Hospital Administrative Datasets.

B. Kaffenberger, A. Hinton, S. Krishna, 2018, Journal of the American Academy of Dermatology.

Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise.

C. Nelson, A. Dobry, K. Motaparthi, 2023, JAMA dermatology.

A description of Kaposi sarcoma risk factors and outcomes in HIV-positive and HIV-negative patients at a tertiary care medical center from 2005 to 2020

B. Kaffenberger, S. Himed, A. Korman, 2023, Archives of Dermatological Research.

Multiple Plantar Poromas in a Stem Cell Transplant Patient

B. Kaffenberger, C. Chung, L. Pootrakul, 2020, Cureus.

A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema

B. Kaffenberger, S. Tolliver, Jaqueline Graham, 2018, International journal of dermatology.

Evaluation of Dundee and ALT-70 predictive models for cellulitis in 56 patients who underwent tissue culture

B. Kaffenberger, A. Mostaghimi, C. Chung, 2022, Archives of Dermatological Research.

Toxic epidermal necrolysis and early transfer to a regional burn unit: is it time to reevaluate what we teach?

B. Kaffenberger, M. Rosenbach, 2014, Journal of the American Academy of Dermatology.

Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment

B. Kaffenberger, M. Forouzandeh, Nicole Natarelli, 2023, Journal of Personalized Medicine.

The necessity of clinicopathologic correlation: syphilis that could have been missed

B. Kaffenberger, A. Gru, J. R. Duncan, 2016, Journal of cutaneous pathology.

Older DRESS patients are more likely to have cytopenias: a retrospective cohort study

B. Kaffenberger, A. Korman, Matthew A Gallardo, 2023, International Journal of Dermatology.

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.

E. Oppel, B. Kaffenberger, M. Rosenbach, 2023, JAMA dermatology.

Viral Reactivation in Hospitalized DRESS Patients: A Retrospective Study from a Tertiary Medical Center in the United States.

B. Kaffenberger, J. Trinidad, N. Milani-Nejad, 2020, Journal of the American Academy of Dermatology.

Impact of social determinants of health on hospital patient outcomes in cutaneous lupus erythematosus

B. Kaffenberger, S. Himed, A. Korman, 2022, International journal of dermatology.

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid

T. Olencki, B. Kaffenberger, S. Scrape, 2018, International journal of dermatology.

Validation of generalized drug‐related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes

B. Kaffenberger, N. Milani-Nejad, M. Amigo, 2021, The British journal of dermatology.

Recurrent desquamative vulvovaginitis in a young woman

B. Kaffenberger, G. McKinley, 2016, International Journal of Dermatology.

A descriptive study of black women with and without hair loss and their perception of dermatologists

B. Kaffenberger, A. Alexis, D. Shipp, 2019, International journal of dermatology.

Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.

B. Kaffenberger, Frances T. Tian, Polina M Vaynshtok, 2016, Dermatology online journal.

Risk factors for loss of follow-up after asynchronous dermatology eConsult concerning for skin cancer

E. Levine, B. Kaffenberger, S. Himed, 2022, Archives of Dermatological Research.

Dupilumab for refractory sclerotic‐type cutaneous graft‐versus‐host disease

B. Kaffenberger, R. Mital, Sam L. Penza, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Diagnostic methods for the confirmation of non-purulent cellulitis: a review

B. Kaffenberger, A. Korman, Henry E. Wang, 2023, Archives of Dermatological Research.

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

G. Hortobagyi, D. Juric, T. Pluard, 2024, NPJ breast cancer.